Warning letter
Marco Pharma International LLC: warning letter of Jan 10, 2020
FDA warning letter 585324 · Division of Human and Animal Food Operations West VI
Key facts
| Reference number | 585324 |
|---|---|
| Company | Marco Pharma International LLC |
| Subject | CGMP/Dietary Supplement/Adulterated/Misbranded |
| Issue date | Jan 10, 2020 |
| Posted date | Feb 4, 2020 |
| Issuing office | Division of Human and Animal Food Operations West VI |
| Product type | Food/Cosmetics |
| CFR sections cited | 111.210(h)(3), 101, 101.4, 101.36, 111, 111.55, 111.70, 111.73, 111.103, 111.105, 111.210, 111.260 and 20 more |
| Inspection city | Roseburg |
| Inspection ZIP | 97470 |
| Inspection start date | May 14, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: